Canada Pension Plan Investment Board
MNPR icon

Canada Pension Plan Investment Board’s Monopar Therapeutics MNPR Stock Holding History

Canada Pension Plan Investment Board’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,400
Closed -$91.4K – 1894
2025
Q4 		$91.4K Buy
+1,400
New +$114K ﹤0.01% 1827

Other funds holding MNPR

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Canada Pension Plan Investment Board's MNPR Position: Q1 2026 in Review

Canada Pension Plan Investment Board sold out of Monopar Therapeutics (MNPR) in Q1 2026, closing a stake of 1,400 shares — an estimated $91.4K sold.

Canada Pension Plan Investment Board first reported a position in MNPR in Q4 2025 and held it in 1 quarter. The position peaked at $91.4K in Q4 2025. 82 funds tracked by Wall St. Rank hold MNPR as of Q1 2026.

  • Canada Pension Plan Investment Board reported no remaining Monopar Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 1,400 Monopar Therapeutics shares in Q1 2026, an estimated $91.4K.
  • Canada Pension Plan Investment Board first reported a position in Monopar Therapeutics in Q4 2025 and held it in 1 quarter.
  • Canada Pension Plan Investment Board's Monopar Therapeutics position peaked at $91.4K in Q4 2025.
  • 82 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.